Mechanism Study of Metabolic Response and Health Benefit Induced by Exercise
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
This study is a single-arm, self-control, single-center study to investigate the mechanism under exercise inducing metabolic response and health benefit. 40 overweight/obese patients with prediabetes will be recruited in this study and instructed to participate in an 8-week exercise program. We aim to investigate 1) the changes of phenotypes such as body weight, body fat, laboratory values, appetite, resting energy expenditure, myokine-adipokine before and after exercise 2) the changes of serum metabolomics 3) search for potential biomarkers of exercise through multi-omics integrated analysis of metabolomics, metagenomics, phenomics, single-cell transcriptome, etc.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2024
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 25, 2024
CompletedFirst Posted
Study publicly available on registry
October 9, 2024
CompletedStudy Start
First participant enrolled
October 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 9, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 9, 2027
October 9, 2024
October 1, 2024
3 years
September 25, 2024
October 8, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Changes of serum metabolites detected by metabolomic profiling
From enrollment to the end of exercise intervention at 8 weeks
Secondary Outcomes (2)
Changes of anthropometrics including body weight, body fat, waist-to-hip ratio
From enrollment to the end of exercise intervention at 8 weeks
Changes of laboratory values including plasma glucose, insulin, lipids, liver enzymes, thyroid hormones, inflammation cytokines
From enrollment to the end of exercise intervention at 8 weeks
Other Outcomes (4)
Changes of resting energy expenditure
From enrollment to the end of exercise intervention at 8 weeks
Changes of fecal microbial composition detected by metagenomics
From enrollment to the end of exercise intervention at 8 weeks
Changes of serum proteins detected by proteomics
From enrollment to the end of exercise intervention at 8 weeks
- +1 more other outcomes
Study Arms (1)
exercise intervention
EXPERIMENTALInterventions
Patients will participate in an 8-week supervised aerobic exercise program, the intensity was set at the moderate to vigorous intensity (≥150mins/week exercise on the treadmill).
Eligibility Criteria
You may qualify if:
- Han Chinese
- mmol/L≤fasting blood glucose\<7 mmol/L, and/or 7.8 mmol/L≤2h-postload glucose\<11.1mmol/L, and/or 5.7% ≤HbA1c\<6.5% without anti-hyperglycemic medicine treatment
- Voluntary participation and provide informed consent
You may not qualify if:
- Participated in any clinical study in relation to weight-loss in the past 1 year
- Had a weight change of more than 10% present weight in the past 1 year
- Had a drug usage not suitable for this study in the past 3 months, such as hormone drug, orlistat, metformin, GLP-1 receptor agonists, lipid-lowering agents, liver protection drug, etc
- Presence of diseases influencing glucose and lipid metabolism ,such as hyperthyroidism, hypothyroidism, Cushing syndrome, etc
- Poorly controlled blood pressure: systolic blood pressure≥180mmHg, and/or diastolic blood pressure≥100mmHg
- Presence of serious heart, liver, kidney or systemic diseases
- Presence of skeletal and muscular diseases which make it difficult to exercise
- Received any kind of surgery in the past 1 year
- COVID-19 positive or recovery from COVID-19 within 4 weeks
- Presence of eating disorders or have a history of eating disorders
- Presence of sleep disorders
- Work in disrupted circadian rhythms
- Pregnancy and breastfeeding women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 25, 2024
First Posted
October 9, 2024
Study Start
October 9, 2024
Primary Completion (Estimated)
October 9, 2027
Study Completion (Estimated)
October 9, 2027
Last Updated
October 9, 2024
Record last verified: 2024-10